Using measurements of the enzymatic activity of MAO-A in the prefrontal cortex, it has been suggested that changes in MAO-A and B levels occur early in AD and remain at the same levels with increasing duration of the disease [18]. The gene discussed is MAOA; the disease is Alzheimer disease.